Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Clinical, Histologic, and Immunophenotypic Features of Serrated Polyps in Patients With Inflammatory Bowel Disease.

Yang C, Tarabishy Y, Dassopoulos T, Nalbantoglu I.

Gastroenterology Res. 2018 Oct;11(5):355-360. doi: 10.14740/gr1064w. Epub 2018 Oct 1.

2.

Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1.

Reinisch W, Bressler B, Curtis R, Parikh A, Yang H, Rosario M, Røseth A, Danese S, Feagan B, Sands BE, Ginsburg P, Dassopoulos T, Lewis J, Xu J, Wyant T.

Inflamm Bowel Dis. 2018 Oct 5. doi: 10.1093/ibd/izy304. [Epub ahead of print]

PMID:
30295811
3.

Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.

Johnson CM, Dassopoulos T.

Curr Gastroenterol Rep. 2018 Sep 28;20(11):53. doi: 10.1007/s11894-018-0658-1. Review.

PMID:
30267281
4.

Knowledge Gaps in the Management of Postoperative Crohn's Disease: A US National Survey.

Nguyen VQ, Mays JL, Lang M, Wu Y, Dassopoulos T, Regueiro M, Moss A, Proctor DD, Sorrentino D.

Dig Dis Sci. 2018 Jan;63(1):53-60. doi: 10.1007/s10620-017-4844-z. Epub 2017 Nov 17.

PMID:
29147878
5.

Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.

Brant SR, Okou DT, Simpson CL, Cutler DJ, Haritunians T, Bradfield JP, Chopra P, Prince J, Begum F, Kumar A, Huang C, Venkateswaran S, Datta LW, Wei Z, Thomas K, Herrinton LJ, Klapproth JA, Quiros AJ, Seminerio J, Liu Z, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, Dryden GW, Hanson JS, Hou JK, Hussain SZ, Hyams JS, Isaacs KL, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kwon JH, Lazarev M, Li E, Mack D, Mannon P, Moulton DE, Newberry RD, Osuntokun BO, Patel AS, Saeed SA, Targan SR, Valentine JF, Wang MH, Zonca M, Rioux JD, Duerr RH, Silverberg MS, Cho JH, Hakonarson H, Zwick ME, McGovern DP, Kugathasan S.

Gastroenterology. 2017 Jan;152(1):206-217.e2. doi: 10.1053/j.gastro.2016.09.032. Epub 2016 Sep 28.

6.

Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.

Lee SD, Rubin DT, Sandborn WJ, Randall C, Younes Z, Schreiber S, Schwartz DA, Burakoff R, Binion D, Dassopoulos T, Arsenescu R, Gutierrez A, Scherl E, Kayhan C, Hasan I, Kosutic G, Spearman M, Sen D, Coarse J, Hanauer S.

Inflamm Bowel Dis. 2016 Aug;22(8):1870-80. doi: 10.1097/MIB.0000000000000805.

7.

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.

Sorrentino D, Marino M, Dassopoulos T, Zarifi D, Del Bianco T.

PLoS One. 2015 Dec 15;10(12):e0144900. doi: 10.1371/journal.pone.0144900. eCollection 2015.

8.

Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.

Huang C, Haritunians T, Okou DT, Cutler DJ, Zwick ME, Taylor KD, Datta LW, Maranville JC, Liu Z, Ellis S, Chopra P, Alexander JS, Baldassano RN, Cross RK, Dassopoulos T, Dhere TA, Duerr RH, Hanson JS, Hou JK, Hussain SZ, Isaacs KL, Kachelries KE, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kumar A, Kwon JH, Lazarev M, Mannon P, Moulton DE, Osuntokun BO, Patel A, Rioux JD, Rotter JI, Saeed S, Scherl EJ, Silverberg MS, Silverman A, Targan SR, Valentine JF, Wang MH, Simpson CL, Bridges SL, Kimberly RP, Rich SS, Cho JH, Rienzo AD, Kao LWH, McGovern DPB, Brant SR, Kugathasan S.

Gastroenterology. 2015 Nov;149(6):1575-1586. doi: 10.1053/j.gastro.2015.07.065. Epub 2015 Aug 14.

9.

Corrigendum: Impact of Retroflexion Vs. Second Forward View Examination of the Right Colon on Adenoma Detection: A Comparison Study.

Kushnir VM, Oh YS, Hollander T, Chen CH, Sayuk GS, Davidson N, Mullady D, Murad FM, Sharabash NM, Ruettgers E, Dassopoulos T, Easler JJ, Gyawali CP, Edmundowicz SA, Early DS.

Am J Gastroenterol. 2015 Jun;110(6):942. doi: 10.1038/ajg.2015.144. No abstract available.

PMID:
26052780
10.

Ulcerative Colitis Care Pathway.

Dassopoulos T, Cohen RD, Scherl EJ, Schwartz RM, Kosinski L, Regueiro MD.

Gastroenterology. 2015 Jul;149(1):238-45. doi: 10.1053/j.gastro.2015.05.036. Epub 2015 May 27. Review. No abstract available.

PMID:
26025078
11.

Impact of retroflexion vs. second forward view examination of the right colon on adenoma detection: a comparison study.

Kushnir VM, Oh YS, Hollander T, Chen CH, Sayuk GS, Davidson N, Mullady D, Murad FM, Sharabash NM, Ruettgers E, Dassopoulos T, Easler JJ, Gyawali CP, Edmundowicz SA, Early DS.

Am J Gastroenterol. 2015 Mar;110(3):415-22. doi: 10.1038/ajg.2015.21. Epub 2015 Mar 3. Erratum in: Am J Gastroenterol. 2015 Jun;110(6):942.

12.

Magnetic resonance enterography in the evaluation of Crohn's disease: a primer for the gastroenterologist.

Fowler KJ, Dassopoulos T, Raptis C.

Inflamm Bowel Dis. 2014 Nov;20(11):2179-88. doi: 10.1097/MIB.0000000000000132. Review.

PMID:
25054338
13.

A general framework for wireless capsule endoscopy study synopsis.

Zhao Q, Mullin GE, Meng MQ, Dassopoulos T, Kumar R.

Comput Med Imaging Graph. 2015 Apr;41:108-16. doi: 10.1016/j.compmedimag.2014.05.011. Epub 2014 Jun 10.

PMID:
24974010
14.

Tissue studies in screened first-degree relatives reveal a distinct Crohn's disease phenotype.

Sorrentino D, Avellini C, Geraci M, Dassopoulos T, Zarifi D, Vadalaʼ di Prampero SF, Benevento G.

Inflamm Bowel Dis. 2014 Jun;20(6):1049-56. doi: 10.1097/MIB.0000000000000051.

PMID:
24788221
15.

Positioning therapy for Crohn's disease.

Gutierrez A, Dassopoulos T.

Curr Gastroenterol Rep. 2014;16(6):384. doi: 10.1007/s11894-014-0384-2. Review.

PMID:
24682780
16.

Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.

Iskandar HN, Cassell B, Kanuri N, Gyawali CP, Gutierrez A, Dassopoulos T, Ciorba MA, Sayuk GS.

J Clin Gastroenterol. 2014 May-Jun;48(5):423-9. doi: 10.1097/MCG.0000000000000049.

17.

Infliximab vs adalimumab for Crohn's disease: perhaps too early to call it a tie.

Dassopoulos T, Sorrentino D.

Clin Gastroenterol Hepatol. 2014 May;12(5):818-20. doi: 10.1016/j.cgh.2013.12.006. Epub 2013 Dec 14. No abstract available.

PMID:
24342747
18.

American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.

Dassopoulos T, Sultan S, Falck-Ytter YT, Inadomi JM, Hanauer SB.

Gastroenterology. 2013 Dec;145(6):1464-78.e1-5. doi: 10.1053/j.gastro.2013.10.046. Review. No abstract available.

PMID:
24267475
19.

Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.

Dassopoulos T, Dubinsky MC, Bentsen JL, Martin CF, Galanko JA, Seidman EG, Sandler RS, Hanauer SB.

Aliment Pharmacol Ther. 2014 Jan;39(2):163-75. doi: 10.1111/apt.12555. Epub 2013 Nov 17.

20.

Practical guide to understanding Comparative Effectiveness Research (CER).

Neely JG, Sharon JD, Graboyes EM, Paniello RC, Nussenbaum B, Grindler DJ, Dassopoulos T; Department of Otolaryngology-Head and Neck Surgery Washington School of Medicine, Saint Louis, Missouri.

Otolaryngol Head Neck Surg. 2013 Dec;149(6):804-12. doi: 10.1177/0194599813506539. Epub 2013 Oct 4.

PMID:
24098005

Supplemental Content

Loading ...
Support Center